Skip to main content

Table 2 Comparisons of Malignant and Benign Patients

From: Relationship between plasma Atherogenic index and final pathology of Bosniak III-IV renal masses: a retrospective, single-center study

  Malignancy  
Malignant
(n = 145, 85.8%)
Benign
(n = 24, 14.2%)
p
Age (year) median (min-max) 61 (33–84) 63 (39–76) a0.472
Gender (n, %) Male 98 (89.9) 11 (10.1) b0.039*
Female 47 (78.3) 13 (21.7)
Side (n, %) Right 73 (86.9) 11 (13.1) b0.682
Left 72 (84.7) 13 (15.3)
Size (cm) median (min-max) 8 (2–18) 5 (3–11) a0.223
Localization (n, %) Lower Pole 23 (88.5) 3 (11.5) b0.848
Middle Pole 82 (84.5) 15 (15.5)
Upper Pole 40 (87.0) 6 (13.0)
Smoking Status (n, %) Exist 105 (90.5) 11 (9.5) b0.009**
None 40 (75.5) 13 (24.5)
Diabetes Mellitus (n, %) Exist 57 (85.1%) 10 (14.9%) b0.827
None 88 (86.3%) 14 (13.7%)
Hypertension (n, %) Exist 95 (90.5%) 10 (9.5%) b0.026*
None 50 (78.1%) 14 (21.9%)
Body Mass Index (kg/m2) mean ± SD 29.30 ± 4.36 27.16 ± 3.27 c0.023*
Triglyceride Value [mg/dl] median (min-max) 156 (68–1019) 164 (100–226) a0.383
HDL-Cholesterole Value [mg/dl] mean ± SD 39.64 ± 11.53 50.04 ± 10.59 c0.001**
Plasma Atherogenic Index Value median (min-max) 0.63 (0.34–1.58) 0.62 (0.39–0.76 a0.003**
  1. aMann Whitney U Test, bPearson Chi-Square Test, cStudent-t Test, *p < 0.05 **p < 0.01